Within the EU-funded ETERNAL project, where Asphalion serves as the regulatory partner, supporting the consortium to ensure alignment with regulatory frameworks while fostering sustainability and innovation, this case study by Angelini Pharma highlights the transformative potential of Twin Screw Granulation (TSG) technology in pharmaceutical manufacturing. TSG enables continuous downstream formulation, significantly reducing energy consumption, minimizing environmental impact, and streamlining production by eliminating unnecessary process steps and minimizing the physical footprint of manufacturing facilities.
Key Benefits of TSG:
• Energy savings: Reduced manufacturing steps and more efficient space-time use
• Environmental impact reduction: Optimized raw material and water usage
• Improved safety: Enhanced through automation and real-time monitoring
• Consistent product quality: Maintained through advanced technology
The technology has successfully moved from R&D trials to pilot-scale testing, further validating its potential for greener pharmaceutical manufacturing
📌 Read the full paper here: ETERNAL CASE STUDY: Continuous Pharmaceutical Manufacturing
For more information about the ETERNAL project, visit www.eternalproject.eu
Need help in your Regulatory projects? Contact us! [email protected]
